82 related articles for article (PubMed ID: 30216645)
1. Heme oxygenase-1 induction mediates chemoresistance of breast cancer cells to pharmorubicin by promoting autophagy via PI3K/Akt pathway.
Pei L; Kong Y; Shao C; Yue X; Wang Z; Zhang N
J Cell Mol Med; 2018 Nov; 22(11):5311-5321. PubMed ID: 30216645
[TBL] [Abstract][Full Text] [Related]
2. Effects of the PI3K/Akt/HO-1 pathway on autophagy in a sepsis-induced acute lung injury mouse model.
Tian J; Li Y; Mao X; Xie K; Zheng Y; Yu Y; Yu Y
Int Immunopharmacol; 2023 Nov; 124(Pt B):111063. PubMed ID: 37857120
[TBL] [Abstract][Full Text] [Related]
3. Silencing PCMT1 enhances the sensitivity of breast cancer cells to paclitaxel through the PI3K/Akt/STMN1 pathway.
Zhang K; Li JY; Li K
Chem Biol Drug Des; 2024 Jun; 103(6):e14559. PubMed ID: 38853025
[TBL] [Abstract][Full Text] [Related]
4. Jatrophone: a cytotoxic macrocylic diterpene targeting PI3K/AKT/NF-κB pathway, inducing apoptosis and autophagy in resistant breast cancer cells.
Shari K; El Gedaily RA; Allam RM; Meselhy KM; Khaleel AE; Abdel-Sattar E
BMC Complement Med Ther; 2023 Aug; 23(1):293. PubMed ID: 37608270
[TBL] [Abstract][Full Text] [Related]
5. DNAJC12 causes breast cancer chemotherapy resistance by repressing doxorubicin-induced ferroptosis and apoptosis via activation of AKT.
Shen M; Cao S; Long X; Xiao L; Yang L; Zhang P; Li L; Chen F; Lei T; Gao H; Ye F; Bu H
Redox Biol; 2024 Apr; 70():103035. PubMed ID: 38306757
[TBL] [Abstract][Full Text] [Related]
6. Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy.
Feliz-Mosquea YR; Christensen AA; Wilson AS; Westwood B; Varagic J; Meléndez GC; Schwartz AL; Chen QR; Mathews Griner L; Guha R; Thomas CJ; Ferrer M; Merino MJ; Cook KL; Roberts DD; Soto-Pantoja DR
Breast Cancer Res Treat; 2018 Nov; 172(1):69-82. PubMed ID: 30056566
[TBL] [Abstract][Full Text] [Related]
7. Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence.
Qin Y; Ashrafizadeh M; Mongiardini V; Grimaldi B; Crea F; Rietdorf K; Győrffy B; Klionsky DJ; Ren J; Zhang W; Zhang X
Cancer Lett; 2023 Aug; 570():216307. PubMed ID: 37451426
[TBL] [Abstract][Full Text] [Related]
8. Oxidized Lipoproteins Promote Resistance to Cancer Immunotherapy Independent of Patient Obesity.
Khojandi N; Kuehm LM; Piening A; Donlin MJ; Hsueh EC; Schwartz TL; Farrell K; Richart JM; Geerling E; Pinto AK; George SL; Albert CJ; Ford DA; Chen X; Kline J; Teague RM
Cancer Immunol Res; 2021 Feb; 9(2):214-226. PubMed ID: 33303575
[TBL] [Abstract][Full Text] [Related]
9. Autophagy-targeted nanoparticles in breast carcinoma: A systematic review.
Golchin A; Maleki M; Alemi F; Malakoti F; Yousefi B
Cell Biol Int; 2023 Nov; 47(11):1767-1781. PubMed ID: 37671447
[TBL] [Abstract][Full Text] [Related]
10. Measurement of Autophagic Activity in Cancer Cells with Flow Cytometric Analysis Using Cyto-ID Staining.
Şansaçar M; Gencer Akçok EB
Methods Mol Biol; 2024 Mar; ():. PubMed ID: 38446407
[TBL] [Abstract][Full Text] [Related]
11. Inflammation-Associated Cytotoxic Agents in Tumorigenesis.
Arnhold J
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201509
[TBL] [Abstract][Full Text] [Related]
12. Cytoprotective Role of Heme Oxygenase-1 in Cancer Chemoresistance: Focus on Antioxidant, Antiapoptotic, and Pro-Autophagy Properties.
Wang H; Cheng Q; Bao L; Li M; Chang K; Yi X
Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37371947
[TBL] [Abstract][Full Text] [Related]
13. Extracellular arginine availability modulates eIF2α O-GlcNAcylation and heme oxygenase 1 translation for cellular homeostasis.
Hung YW; Ouyang C; Ping X; Qi Y; Wang YC; Kung HJ; Ann DK
J Biomed Sci; 2023 May; 30(1):32. PubMed ID: 37217939
[TBL] [Abstract][Full Text] [Related]
14. Preclinical and Basic Research Strategies for Overcoming Resistance to Targeted Therapies in HER2-Positive Breast Cancer.
Cao Y; Li Y; Liu R; Zhou J; Wang K
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174034
[TBL] [Abstract][Full Text] [Related]
15. A Novel Derivative of Curcumol, HCL-23, Inhibits the Malignant Phenotype of Triple-Negative Breast Cancer and Induces Apoptosis and HO-1-Dependent Ferroptosis.
Zhao P; Song H; Gao F; Chen L; Qiu J; Jin J; Pan C; Tang Y; Chen M; Pan Y; Li Y; Huang L; Yang J; Hao X
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110625
[TBL] [Abstract][Full Text] [Related]
16. Breast cancers co-opt normal mechanisms of tolerance to promote immune evasion and metastasis.
Crump LS; Kines KT; Richer JK; Lyons TR
Am J Physiol Cell Physiol; 2022 Nov; 323(5):C1475-C1495. PubMed ID: 36189970
[TBL] [Abstract][Full Text] [Related]
17. Heme oxygenase 1 overexpression induces immune evasion of acute myeloid leukemia against natural killer cells by inhibiting CD48.
Zhang T; Fang Q; Liu P; Wang P; Feng C; Wang J
J Transl Med; 2022 Sep; 20(1):394. PubMed ID: 36058936
[TBL] [Abstract][Full Text] [Related]
18. Potential of the miR-200 Family as a Target for Developing Anti-Cancer Therapeutics.
Jo H; Shim K; Jeoung D
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682560
[TBL] [Abstract][Full Text] [Related]
19. Non-canonical vs. Canonical Functions of Heme Oxygenase-1 in Cancer.
Jagadeesh ASV; Fang X; Kim SH; Guillen-Quispe YN; Zheng J; Surh YJ; Kim SJ
J Cancer Prev; 2022 Mar; 27(1):7-15. PubMed ID: 35419301
[TBL] [Abstract][Full Text] [Related]
20. Reversing an Oncogenic Epithelial-to-Mesenchymal Transition Program in Breast Cancer Reveals Actionable Immune Suppressive Pathways.
Williams MM; Hafeez SA; Christenson JL; O'Neill KI; Hammond NG; Richer JK
Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
